Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new history entry (version 9) with a Study Status update was added for 2026-05-19, expanding the record’s current-state information. The entry dated 2025-12-23 was removed from the history.
    Difference
    0.4%
    Check dated 2026-05-22T07:49:44.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The record history now shows a new Revision: v3.5.4, replacing the prior Revision: v3.5.3. This represents a metadata update to the study record's history rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-05-14T23:07:32.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page footer’s software revision indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” a change related to the ClinicalTrials.gov site build rather than the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-23T21:52:45.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.2, was added to the Record History and the previous v3.5.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-04-16T12:27:11.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Record History now shows revision v3.5.0 and removes v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:27:02.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added to the record history, and an older entry (v3.4.2) was removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:19:36.000Z thumbnail image

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.